University at Buffalo - The State University of New York
Skip to Content
Martin                         Brecher

Martin L. Brecher MD

Department of Pediatrics

Associate Professor

Specialty/Research Focus

Pediatric Hematology-Oncology; Pediatrics

 

Education and Training:
  • Fellowship, Pediatric Hematology/Oncology, University at Buffalo/Roswell Park Cancer Institute (1977)
  • Residency, Pediatrics, University at Buffalo (1975)
  • Internship, Pediatrics, University at Buffalo (1973)
  • MD, Medicine, University at Buffalo (1972)
  • BA, University at Buffalo, magna cum laude (1968)
Employment:
  • Clinical Adjunct Faculty, Rochester Institute of Technology (1998-present)
  • Associate Professor, Pediatrics, University at Buffalo (1985-present)
  • Chair, Pediatric Oncology, Roswell Park Cancer Institute (1990–2016)
  • Chief, Division of Hematology/Oncology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1990–2016)
  • Attending Physician, Division of Hematology/Oncology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1989–2014)
  • Director, Hematology Clinic, Women and Children's Hospital of Buffalo (1988–1991)
  • Acting Chief, Division of Hematology/Oncology, UBMD Pediatrics, Women and Children‘s Hospital of Buffalo (1987–1990)
  • Acting Chairman, Pediatrics, Roswell Park Cancer Institute (1987–1990)
  • Associate Attending Physician, Pediatrics, Women and Children‘s Hospital of Buffalo (1986–1989)
  • Cancer Research Pediatrician, Pediatrics, Roswell Park Cancer Institute (1977–1989)
  • Assistant Attending Physician, Pediatrics, Women and Children‘s Hospital of Buffalo (1985–1986)
  • Assistant Professor, Pediatrics, University at Buffalo (1982–1985)
  • Special Consultant, Pediatric Hematology/Oncology, Women and Children's Hospital of Buffalo (1979–1985)
  • Research Assistant Professor, Pediatrics, University at Buffalo (1977–1982)
  • Research Assistant Instructor, Pediatrics, University at Buffalo (1975–1977)
  • Clinical Assistant Instructor, Pediatrics, University at Buffalo (1972–1975)
See all (6 more)
Awards and Honors:
  • Buffalo Spree Magazine: Western New York‘s Top 100 Doctors (2006)
  • The Leonard Tow Humanism in Medicine Award (2005)
  • Leukemia and Lymphoma Society of Western New York: Service Award (2004)
  • AcademicKeys: Who's Who in Medical Sciences Education (WWMSE) (2004)
  • Camp Good Days and Special Times: Spirit of Teddi Humanitarian Award (2003)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Alumni Achievement Award (2002)
  • Women and Children‘s Hospital of Buffalo: Burt P. Flickinger Jr. Physician Award (2001)
  • Guide to Top Doctors (2001)
  • University at Buffalo/Women and Children's Hospital of Buffalo: John Paroski House Staff Teaching Award in Pediatrics (1997)
  • Leukemia Society of America: Outstanding Professional Achievement (1989)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Louis A. and Ruth Siegel Distinguished Teaching Award (1987)
  • University at Buffalo/Women and Children's Hospital of Buffalo: Frederick B. Wilkes Teaching Award in Pediatrics (1984)
  • The Best Doctors in America, Northeast Region (1996-1997)
  • Guide to America's Top Pediatricians (2004-2005)
  • Leukemia Society of America: Supporting Trustee Award (1997, 1998)
  • Castle Connolly Medical Ltd: Best Doctors in America (1998-1999, 1999-2000, 2000-2001, 2001-2002, 2002-2003, 2007-2008, 2009-2010, 2011-2012)
  • Castle Connolly Medical Ltd.: America‘s Top Doctors for Cancer (2005, 2010)
  • Buffalo Spree Magazine: Western New York‘s Best Doctors (2005, 2011, 2012)

Grants and Sponsored Research:
  • August 2010–August 2011
    Adolescent and Young Adult Program
    Hyundai Hope on Wheels
    Role: Principal Investigator
    $80,000
  • June 2009–May 2011
    SES, Race, and Patterns of Health Care Navigation of Parents of Pediatric Cancer Patients
    NCI
    Role: Co-Investigator
    $331,992
  • August 2007–August 2009
    Integrated Target & Drug Discovery Program in Childhood Cancers
    RPCI Alliance Foundation
    Role: Co-Principal Investigator
    $375,000
  • March 2003–July 2005
    Long-Term Effects of CNS Therapy on Survivors of Childhood ALL: 25 Year Follow-Up
    RPCI Alliance Foundation
    Role: Principal Investigator
    $30,000

Journal Articles:
See all (57 more)
Abstracts:
  • Weiner M, Leventhal B, Brecher M, Marcus R, Cantor A, Ternberg J, Behm F, Wharam M, Gieser P. A Randomized Study of Intensive MOPP-ABVD /- Low Dose Total Nodal Radiation Therapy in the Treatment of Stages IIB, IIIA2, IIIB, IV Hodgkin‘s Disease in Pediatric Patients. Proc Am Soc Clin Oncol. 1995; 14.
  • Karamanoukian HL, O‘Toole S, Brecher M, Caty MG, Allen JE, Azizkhan RG, Glick PL. The Disappearing Kidney Following Adrenal or Upper Abdominal Paraaortic Neuroblastoma Resection. Proc Am Pediatr Surg Assoc. 1995.
  • Greenberg S, Youngnim C, Du T-L, Rickert MH, Frankel S, Bernstein S, Brecher M. Molecular Identification of Malignant Clones in Central Nervous System Leukemia/Lymphoma. Neurology. 1994; 44(4).
  • Choi Y, Du T-L, Ward P, Overturf P, Brecher M, Ballow M, Greenberg S. Molecular Mechanisms of Clonal Evolution in B-Lineage Acute Lymphoblastic Leukemia. Clin Res. 1994; 42.
  • Brecher M, Voorhees MM, Ritchey AK, Harris MB, Forman E. Adult Heights Achieved by Long-Term Survivors of Childhood Acute Lymphocytic Leukemia (ALL) Treated on Three Different Regimens of Central Nervous System (CNS) Prophylaxis. Proc Soc Pediatr Res. 1992.
  • Chervinsky DS, Brecher M, Hoelcle M. Cremophor-El Reverses Taxol Cross Resistance in Murine C1300 Multidrug Resistant Neuroblastoma Cells. Proc Amer Assoc Cancer Res. 1992; 33.
  • Grossi M, Hoernig L, Brecher M, Fitzpatrick JE, Sweeney J. Von Willebrand Factor in Childhood Cancer. Proc Amer Soc Clin Oncol. 1992; 11.
  • Brecher M, Murphy SB, Bowman P, Sullivan M, Shuster JJ, Berard C. Results of Pediatric Oncology Group (POG) 8616: A Randomized Trial of Two Forms of Therapy for Stage III Diffuse, Small Non-Cleaved Cell Lymphoma in Children. Proc Amer Soc Clin Oncol. 1992; 11.
  • Srivastava BIS, Chervinsky DS, Grossi M, Brecher M. A Pediatric Patient with Acute Leukemia Involving Progenitors of Dendritic Langerhans Cells (DLCs). Proc Amer Assoc Cancer Res. 1992; 33.
  • Green DM, Yakar D, Brecher M, Lindsay AN, MacGillivray MH, Voorhess ML. Ovarian Function in Adolescent Women Following Successful Treatment of Non-Hodgkin's Lymphoma. Proc Amer Soc Clin Oncol. 1992; 1.
  • Baer MR, Naughton MJ, Nettelton AC, Stewart SJ, Barcos MP, Block AW, Brecher M, Bloomfield CD, Stewart CC. Multiparameter Flow Cytometric Analysis of Acute Myeloid Leukemia (AML) Cells. Blood. 1991; 78.
  • Chervinsky DS, Brecher M, Baker R, Hoelcle M. Cremophor-El (a Solvent for Cyclosporine-A) Reverses Multidrug Resistance in C1300 Neuroblastoma. Proc Amer Assoc Cancer Res. 1991; 32.
  • Brecher M, Ochs J, Freeman A, Pollock B, Mahoney D, Ragab A. Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL) in Children with Combination Chemotherapy and Alpha Interferon (IDN). A Pediatric Oncology Group Pilot Study. Proc Amer Assoc Cancer Res. 1989; 30.
  • Weiner M, Leventhal B, Brecher M, Marcus R, Ternberg J. Gallium-67 Scans (Ga-67) as an Adjunct to Clinical Restaging in Pediatric Patients with Hodgkin's Disease (HD). Proc Amer Soc Clin Oncol. 1989; 8.
  • Heary M, Brecher M, Zevon M, Green DM, Neubauer N. Relationship Between Illness Impact, Information, and Satisfaction with Medical Treatment in Pediatric Outpatients. Proc Amer Soc Clin Oncol. 1988; 7.
  • Grossi M, Maipang M, Brecher M, Green DM, Tebbi C, Freeman A. Use of VP-16 and Cyclophosphamide (CPM) in the Treatment of Acute Monoblastic Leukemia (AMOL) in Children. Proc Amer Soc Clin Oncol. 1988; 7.
  • Green DM, Brecher M, Douglass HO, Mindell ER, Ettinger LJ, Tebbi CK. The Treatment of Pediatric Patients with Osteosarcoma of an Extremity: Does Pre-Operative Intra-Arterial Chemotherapy Affect Prognosis?. Proc Amer Assoc Cancer Res. 1987; 28.
  • Brecher M, Weinberg V, Boyett JM, Sinks LF, Jones B, Glicksman A, Holland J, Freeman AI. Intermediate Dose Methotrexate in Childhood Acute Lymphoblastic Leukemia Resulting in Decreased Incidence of Testicular Relapse. 1987 Yearbook of Cancer. 1987.
  • Cohen ME, Duffner PK, Heffner RR, Lacey D, Brecher M. Long-Term Survivors of Brain Stem Gliomas. Ann Neurol. 1985; 18.
  • Green DM, Voorhess ML, Panahon A, Pearce J, MacGillivray MH, Brecher M. The Relationship Between Peak Serum TSH Level and Recovery from Post-Irradiation Thyroid Hypo-function. Proc Int Soc Pediatr Oncol. 1985; 17.
  • Weiner M, Leventhal V, Falletta J, Brecher M. Treatment for Advanced Hodgkin's Diseases (HD) in Children. Proc Amer Assoc Cancer Res. 1985; 26.
  • Green DM, Rosenberg HS, Cangir A, Brecher M, Simpson L, Fisher J, Allen JE, Cooney DR, Jewett TC, Tebbi CK, Freeman AI. Fatal Pulmonary Fibrosis in an Infant Treated with a Combination Chemotherapy Regimen Containing Bleomycin for Presacral Yolk Sac Tumor. Proc Amer Assoc Cancer Res. 1985; 26.
  • Freeman AI, Brecher M, Boyett J, Sinks LF, Weinberg V, Jones B, Holland JF. Relapse Following Cessation of Therapy in Childhood Acute Lymphocytic Leukemia (ALL): Effects of "End Intensification" (EI). Proc Amer Soc Clin Oncol. 1985; 4.
  • Cohen ME, Duffner PK, Heffner RR, Lacey D, Brecher M. Long-Term Survivors of Brain Stem Gliomas. Proc Amer Soc Clin Oncol. 1985; 4.
  • Brecher M, Boyett J, Sinks LF, Green DM, Weinberg VJ, Jones B, Freeman AI. Factors Predictive of Isolated Central Nervous System (CNS) Relapse in Children with Acute Lymphocytic Leukemia (ALL) Following CNS Prophylaxis with Intrathecal Methotrexate (ITMTX) and Intermediate Dose Methotrexate (IDM). Proc Amer Soc Clin Oncol. 1985; 4.
  • Humbert JR, Brecher M. Auto-Oxidation of Neutrophils (PMNs) in Pediatric Lymphoma Patients During Remission. Blood. 1984; 64(5).
  • Green DM, Brecher M, Simpson I, Fisher J, Allen JE, Cooney DR, Jewett TC, Tebbi CK, Freeman AI. The Treatment of Yolk Sac Tumor with Bleomycin (B), Vincristine (V), and Cis-Plantinum (P) Followed by V, Actinomycin D (A) and Cyclophosphamide (C). Proc Amer Assoc Cancer Res. 1984; 25.
  • Green DM, Brecher M, Freeman AI. Invasive Infection due to Hemophilus Influenza - A Late Complication of Staging Laparotomy for Hodgkin‘s Disease. Proc Amer Soc Clin Oncol. 1984; 3.
  • Green DM, Blumenson LE, Brecher M, Grossi M, Freeman AI. Do Pneumococcal Vaccine (PV) and Prophylactic Antibiotics (PA) Prevent Pneumococcal Bacteremia (PB) in Splenectomized Pediatric Patients with Hodgkin's Disease?. Proc Amer Assoc Cancer Res. 1983; 24.
  • Bauer F, Tebbi C, Preisler H, Rustum YM, Brecher M, O'Leary M, Freeman A. High Dose Cytosine Arabinoside (HDAC) for Childhood Leukemia. Proc Amer Soc Clin Oncol. 1983; 2.
  • Brecher M, Voorhess ML, MacGillivray MH, Hollogittas J, Harris M, Dasgupta I, Vasquez A, Jones B, Glicksman A, Glidewell O, Freeman A. Growth Hormone (GH) Deficiency Following Central Nervous System (CNS) Prophylaxis Consisting of Intrathecal Methotrexate (ITMTX) Alone or in Combination with Intermediate Dose Methotrexate (IDM) in Children with Acute Lymphocytic Leukemia (Cancer and Leu. Proc Amer Soc Clin Oncol. 1983; 2.
  • Duffner PK, Cohen ME, Anderson S, Voorhess ML, MacGillivray MH, Panahon A, Brecher M. Long-Term Effects of Treatment on Endocrine Function in Children with Brain Tumors. Child Neurol Soc. 1983.
  • Green DM, Yakar D, Voorhess ML, Brecher M, MacGillivray MH. Evaluation of Patients with Post-Irradiation Thyroid Dysfunction. Clin Res. 1982; 30.
  • Green DM, Brecher M, Grossi M, Simpson I, Fisher J, Allen JE, Cooney DR, Jewett TC, Freeman AI. The Treatment of Yolk Sac Tumor with Rotational Combination Chemotherapy. Proc Amer Acad Pediatr Hematol-Oncol. 1982.
  • Grossi M, Kowalcyzk J, Suh O, Minowada J, Brecher M, Green DM, Freeman AI, Sandberg AA. Chromosomes as a Prognostic Factor (PF) in Children and Adolescents with Acute Lymphoblastic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1982; 1.
  • Green DM, Brecher M, Grossi M, Wang JJ, Sinks LF, Freeman AI. Intermediate Dose Methotrexate (IDM) for Childhood Acute Lymphoblastic Leukemia (ALL). Proc Amer Assoc Cancer Res. 1982; 23.
  • Cohen ME, Duffner PK, Brecher M, Diamond LS, Glicksman A, Forman E, Harris M, Jones B, Holland J, Glidewell O, Freeman AI. EEGs in Disease-free Children with Acute Lymphocytic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1982; 1.
  • Sullivan MP, Ramirez I, Brecher M. High Cytoxan - High Methotrexate (MTX) Therapy for Burkitt's Lymphoma: A Therapeutic Model for Stage III and IV Non-Lymphoblastic Lymphoma of Chilldhood. Proc Amer Soc Clin Oncol. 1982; 1.
  • Freeman AI, Weinberg V, Brecher M, Jones B, Glicksman A. Comparison of Intermediate Dose Methotrexate (IDM) with Cranial Irradiation (CRT) in Acute Lymphocytic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1982; 1.
  • Rowland J, Glideswell O, Sibley R, Holland JC, Brecher M, Tull R, Herman A, Glicksman A, Forman E, Harris M, McSweeney J, Jones B, Black M, Cohen ME, Freeman AI. Effect of Cranial Radiation (CRT) on Neuropsychologic Function in Children with Acute Lymphocytic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1982; 1.
  • Preisler HD, Brecher M, Browman G, Early AP, Walker IR, Raza A, Freeman AI. Treatment of AML in Children and Young Adults. Blood. 1981; 58(5).
  • Green DM, Ghoorah J, Douglass HO, Allen JE, Berjian RJ, Jewett TC, Brecher M, Henderson ES, Freeman AI. The Results of Staging Laparotomy in Pediatric Patients with Hodgkin's Disease. Proc Amer Fed Clin Res. 1981.
  • Voorhess ML, Brecher M, MacGillivray MH, Hologgitas J, Harris M, Dasgupta A, Vasquez A, Glidewell O. Effect of Different Forms of Central Nervous System (CNS) Prophylaxis on Pituitary Function of Children with Acute Lymphocytic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1981; 22.
  • Freeman AI, Weinberg VE, Brecher M, Jones B, Glicksman A. Comparison of Intermediate Dose Methotrexate (IDM) with Cranial Irradiation (CRT) in Children with Acute Lymphocytic Leukemia (ALL). Proc Amer Soc Clin Oncol. 1981; 22.
  • Brecher M, Gardner RV, Ettinger LJ, Green DM, Freeman AI. Intensive Chemotherapy for Treatment of Advanced Burkitt's Lymphoma. Proc Amer Soc Clin Oncol. 1981; 22.
  • Green DM, Brecher M, Freeman AI. The Use of Intermediate Dose Methotrexate (MTX) in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison of Three versus Six Courses. Proc Amer Assoc Cancer Res. 1981; 22.
  • Green DM, Brecher M, Lindsay AN, Yakar D, Voorhess ML, MacGillivray MH, Freeman AI. Thyroid Function in Pediatric Patients After Neck Irradiation for Hodgkin's Disease. Proc Amer Assoc Cancer Res. 1980; 21.
  • Brecher M, Thomas PRM, Sinks LF, Freeman AI. Updated Results on the Treatment of Childhood Non-Hodgkin's Lymphoma (NHL). Proc Amer Soc Clin Oncol. 1979; 20.
  • Ochs JJ, Brecher M, Sinks LF, Freeman AI. Computed Tomography (CT) Scans in Children with Acute Lymphocytic Leukemia (ALL) Following CNS Prophylaxis without Radiotherapy. Proc Amer Soc Clin Oncol. 1978; 19.
  • Creaven PJ, Malicz T, Brecher M, Wang JJ, Freeman AI. Methotrexate Levels in Cerebrospinal Fluid During a Simultaneous Intraventricular and High-Dose Intravenous Administration. Proc Amer Assoc Cancer Res. 1977; 18.
  • Brecher M, Freeman AI, Panahon AA. Childhood Non-Hodgkin's Lymphoma. Proc Amer Soc Clin Oncol. 1976; 17.
  • Brecher M, Freeman AI, Panahon AA. Childhood Non-Hodgkin's Lymphoma. Proc Amer Soc Hematol. 1975.
See all (42 more)
Books and Book Chapters:
  • Raghavan D, Brecher M, Johnson DH, Meropol NJ, Moots PL, Rose PG. Textbook of Uncommon Cancer, Third Edition. 2006.
  • Brecher M, Roberts J, Petruzzi MJ. "Hematology-Oncology Problems in the Intensive Care Unit". Pediatric Critical Care, Third Edition. 2006.
  • Bambach BJ, Brecher M. "Pediatric Soft Tissue Sarcomas". Problems in General Surgery. 1999; 16(3).
  • Raghavan D, Brecher M, Johnson DH, Meropol NJ, Moots PL, Thigpen JT. Textbook of Uncommon Cancer, Second Edition. 1999.
  • Brecher M. "Acute Leukemia in Children". Conn's Current Therapy. 1995.
  • Brecher M. "Principles of Chemotherapy". Brain Tumors in Children: Principles of Diagnosis and Treatment, Second Edition. 1994.
  • Brecher M. "Management of Malignant T-Cell (Lymphoblastic) Lymphomas and Other Non-Hodgkin's Lymphomas". Neoplastic Diseases of Childhood. 1993.
  • Brecher M. "Hodgkin's Disease in Adolescents". Major Topics in Adolescent Oncology. 1987.
  • Freeman AI, Brecher M. "Acute Lymphoblastic Leukemia in Childhood". Current Therapy in International Medicine. 1987.
  • Freeman AI, Brecher M. "Acute Lymphoblastic Leukemia in Childhood". Current Therapy in Hematology-Oncology. 1985.
  • Brecher M. "Diagnosis and Treatment of Childhood Acute Lymphoblastic Leukemia". Neoplastic Diseases of the Blood and Blood-Forming Organs. 1985.
  • Brecher M, Freeman AI. "Principles of Chemotherapy". Brain Tumors in Children: Principles of Diagnosis and Management. 1984.
  • Kaplan RE, Cooney DE, Brecher M, Jewett TC. "Neuroblastoma: A Review of One Center's Experience Over Four Decades". Sixth Annual Robert E. Gross Lectureship in Pediatric Surgery. 1984.
  • Freeman AI, Weinberg V, Green DM, Brecher M. "Intermediate Dose Methotrexate (IDM) for the Treatment of Childhood Acute Lymphocytic Leukemia (ALL)". Current Drugs and Methods of Cancer Treatment. 1983.
  • Brecher M. "Soft Tissue Sarcomas in Children and Adolescents". Major Topics in Pediatric and Adolescent Oncology. 1982.
  • Horoszewicz J, Leong S, Dolen J, Brecher M, Tebbi C, Freeman AI, Aungst W, Mirand E. "Human Fibroblast Interferon as a Potential Anticancer Drug - Phase I Studies on Intravenous and Intrathecal Administration". International Symposium on New Trends in Human Immunology and Cancer Immunotherapy. 1980.
  • Freeman AI, Brecher M, Wang JJ, Sinks LF. "Intermediate Dose Methotrexate (IDM) in Childhood Acute Lymphocytic Leukemia (ALL)". Modern Trends in Human Leukemia III. 1979.
  • Freeman AI, Brecher M. "Non-Hodgkin's Lymphoma in Children". Pediatric Cancer Therapy. 1979.
See all (8 more)

Professional Memberships:
  • American Society of Clinical Oncology
  • American Association for Cancer Research
  • American Academy of Pediatrics
  • Buffalo Pediatric Society
  • American Society of Hematology
  • American Society of Pediatric Hematology/Oncology
  • American Histolytic Society
Presentations:
  • "When to Suspect Malignancies in Children" Grand Rounds, WCA Hospital (2011)
  • "Adjustment in Adolescent and Young Adult Cancer Patients: Coping, Self-Image, Emotional, and Family Dimensions" 42nd Congress, International Society of Pediatric Oncology (SIOP) (2010)
  • "Deletions Involving 9p in Acute Lymphoblastic Leukemia" Annual Meeting, American Society of Human Genetics (2009)
  • "Acute Leukemia" Grand Rounds, Sister's Hospital (2008)
  • "Ewings Sarcoma of Mandibular Condyle: Multidisciplinary Management Optimizes Outcome" Annual Meeting, American Head and Neck Society (2007)
  • "Medical Issues of Students Currently Undergoing Treatment" Cancer in the Classroom, University at Buffalo (2007)
  • "Infectious Diseases" Division QA Grand Rounds, Women and Children's Hospital of Buffalo (2005)
  • "Emergency Oncology" Resident Lecture, Women and Children's Hospital of Buffalo (2004)
  • "Office Work-Up of Anemia" Grand Rounds, Mercy Hospital of Buffalo (2003)
  • "Physical and Physiological Aspects of Childhood Cancer" Cancer in the Classroom, University at Buffalo (2003)
  • "Sarcoma in Children and Adolescents" Surgical Grand Rounds, Roswell Park Cancer Institute (2003)
  • "Childhood Leukemias: Cytogenetics and Bone Marrow Transplantation" 17th International Cancer Congress, Union for International Cancer Control (UICC) (1998)
  • "A Randomized Study of Intensive MOPP-ABVD+/- Low Dose Total Nodal Radiation Therapy in the Treatment of Stages IIB, IIIA2, IIIB, IV Hodgkin's Disease in Pediatric Patients" Annual Meeting, American Society of Clinical Oncology (1995)
  • "The Disappearing Kidney Following Adrenal or Upper Abdominal Paraaortic Neuroblastoma Resection" Annual Meeting, American Pediatric Surgical Association (1995)
  • "Molecular Identification of Malignant Clones in Central Nervous System Leukemia/Lymphoma" Annual Meeting, American Academy of Neurology (1994)
  • "A Randomized Study of Intensive MOPP-ABVD+/- Low Dose Total Nodal Radiation Therapy in the Treatment of Stages IIB, IIIA2, IIIB, IV Hodgkin‘s Disease in Pediatric Patients: A Pediatric Oncology Group Study" XXV Meeting, International Society of Pediatric Oncology (1993)
  • "Recent Advances in Therapy of High-Grade T- and B-Cell Non-Hodgkin's Lymphoma (NHL) iof Childhood" T- and B-Cell Lymphomas, Keystone Symposia (1993)
  • "A Pediatric Patient with Acute Leukemia Involving Progenitors of Dendritic Langerhans Cells (DLCs)" Annual Meeting, American Association for Cancer Research (1992)
  • "Adult Heights Achieved by Long-Term Survivors of Childhood Acute Lymphocytic Leukemia (ALL) Treated on Three Different Regimens of Central Nervous System (CNS) Prophylaxis" Annual Meeting, Society for Pediatric Research (1992)
  • "Cremophor-El Reverses Taxol Cross Resistance in Murine C1300 Multidrug Resistant Neuroblastoma Cells" Annual Meeting, American Association for Cancer Research (1992)
  • "Results of Pediatric Oncology Group (POG) 8616: A Randomized Trial of Two Forms of Therapy for Stage III Diffuse, Small Non-Cleaved Cell Lymphoma in Children" Annual Meeting, American Society of Clinical Oncology (1992)
  • "Von Willebrand Factor in Childhood Cancer" Annual Meeting, American Society of Clinical Oncology (1992)
  • "Recombinant Interferon-Alpha2B (IFN) in Children with Acute Lymphoblastic Leukemia (ALL) in Marrow Relapse" Vth International Symposium on Therapy of Acute Leukemias (1991)
  • "Cremophor-El (a Solvent for Cyclosporine-A) Reverses Multidrug Resistance in C1300 Neuroblastoma" Annual Meeting, American Association for Cancer Research (1991)
  • "Burkitt‘s Lymphoma of the Parapharnygeal Mass" Eastern Section Meeting, The Triological Society (1991)
  • "Parenting and Childhood Cancer: Child Characteristics as Stressors" Annual Scientific Meeting, Society of Behavioral Medicine (1989)
  • "Treatment of Relapsed Acute Lymphoblastic Leukemia (ALL) in Children with Combination Chemotherapy and Alpha Interferon (IDN). A Pediatric Oncology Group Pilot Study" Annual Meeting, American Association for Cancer Research (1989)
  • "Recombinant Alpha Interferon with or without Standard Chemotherapeutic Agents in Relapsed Childhood Acute Lymphoblastic Leukemia" Annual Meeting, International Society of Hematology (1988)
  • "Relationship Between Illness Impact, Information, and Satisfaction with Medical Treatment in Pediatric Outpatients" Annual Meeting, American Society of Clinical Oncology (1988)
  • "Adjustment to Childhood Cancer" Annual Scientific Meeting, Society of Behavioral Medicine (1988)
  • "The Treatment of Pediatric Patients with Osteosarcoma of an Extremity: Does Pre-Operative Intra-Arterial Chemotherapy Affect Prognosis?" Annual Meeting, American Association for Cancer Research (1987)
  • "Decreased Incidence of Testicular Relapse in Childhood Acute Lympho-cytic Leukemia (ALL) Following Treatment with a Regimen Containing Intermediate Dose Methotrexate (IDM)" Annual Meeting, International Union Against Cancer (1986)
  • "Effects of End Intensification (RI) in Acute Lymphocytic Leukemia (ALL)" Annual Meeting, International Union Against Cancer (1986)
  • "The Relationship Between Peak Serum TSH Level and Recovery from Post-Irradiation Thyroid Hypo-function" Annual Meeting, International Society or Pediatric Oncology (1985)
  • "Comparison of Intermediate Dose Methotrexate (UDM) with Cranial Irradiation (CR) for Post-Induction Diagnosis of Acute Lymphocytic Leukemia (ALL) in Children" XI Symposium, International Association for Comparative Research on Leukemia and Related Diseases (1983)
  • "Evaluation of Patients with Post-Irradiation Thyroid Dysfunction" Eastern Section Meeting, American Federation of Clinical Research (1982)
  • "The Treatment of Yolk Sac Tumor with Rotational Combination Chemotherapy" Annual Meeting, American Academy of Pediatric Hematology/Oncology (1982)
  • "The Ratio of Granulocyte-Macrophage and Pleuripotential Hematopoietic Colony Forming Units in Culture (CFU-GM and CFU-GEMM) in Blood and Marrow of Children with Acute Lymphoblastic Leukemia (ALL)" 13th International Cancer Congress, Union for International Cancer Control (UICC) (1982)
  • "Thre Frequency, Course and Possible Prognostic Significance of Joint Manifestations in Acute Leukemia of Children" VII Pan-American Congress of Rheumatology (1982)
  • "Chromosomes as a Prognostic Factor (PF) in Children and Adolescents with Acute Lymphoblastic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1982)
  • "Comparison of Intermediate Dose Methotrexate (IDM) with Cranial Irradiation (CRT) in Acute Lymphocytic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1982)
  • "EEGs in Disease-free Children with Acute Lymphocytic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1982)
  • "Effect of Cranial Radiation (CRT) on Neuropsychologic Function in Children with Acute Lymphocytic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1982)
  • "Intermediate Dose Methotrexate (IDM) for Childhood Acute Lymphoblastic Leukemia (ALL)" Annual Meeting, American Association for Cancer Research (1982)
  • "Ovarian Function in Adolescent Women Following Successful Treatment of Non-Hodgkin's Lymphoma" Annual Meeting, American Society of Clinical Oncology (1982)
  • "The Results of Staging Laparotomy in Pediatric Patients with Hodgkin‘s Disease" Eastern Section Meeting, American Federation for Clinical Research (1981)
  • "Comparison of Intermediate Dose Methotrexate (IDM) with Cranial Irradiation (CRT) in Children with Acute Lymphocytic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1981)
  • "Effect of Different Forms of Central Nervous System (CNS) Prophylaxis on Pituitary Function of Children with Acute Lymphocytic Leukemia (ALL)" Annual Meeting, American Society of Clinical Oncology (1981)
  • "The Use of Intermediate Dose Methotrexate (MTX) in Childhood Acute Lymphoblastic Leukemia (ALL): A Comparison of Three versus Six Courses" Annual Meeting, American Association for Cancer Research (1981)
  • "The Treatment of Primary Childhood Acute Lymphocytic Leukemia with Intermediate Dose Methotrexate" Modern Trends in Human Leukemia III (1978)
  • "High-Dose Methotrexate in Acute Lymphocytic Leukemia" Second International Symposium on Therapy of Acute Leukemias (1977)
See all (41 more)
Service Activities:
  • Women and Children‘s Hospital of Buffalo: Physician Steering Committee for the Aligning Hospital and Physician Incentives Program; Committee Member (2012–present)
  • Women and Children‘s Hospital of Buffalo/Shepley Bulfinch: Roswell Park @ Children‘s Hospital User Group; Member (2012–present)
  • Women and Children‘s Hospital of Buffalo: Shepley Bulfinch Steering Committee; Committee Member (2012–present)
  • Hemophilia Center of Western New York; Board of Directors (2012–present)
  • Women and Children‘s Hospital of Buffalo: Physician Strategic Planning Committee; Committee Member (2009–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Chairman of Pediatrics; Committee Member (2008–2009)
  • Roswell Park Cancer Institute: Clinical Research Services Advisory Committee; Committee Member (2008–present)
  • Roswell Park Cancer Institute: Medical Staff Executive Committee; At-Large Representative (2007–2011)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Ad Hoc Committee on Promotions to Clinical Ranks; Committee Member (2007–2010)
  • Women and Children‘s Hospital of Buffalo: Advisory Council; Member (2006)
  • Women and Children‘s Hospital of Buffalo: Search Committee for Chief of Department of Medicine; Committee Member (2006)
  • Cancer and the Adolescent, Second Edition; Eden TOB, Barr RD, Bleyer A, Whiteson (eds.); Book Reviewer (2005)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Scientific Program Spring Clinical Days; Director (2003–present)
  • National Comprehensive Cancer Network: Pediatric Supportive Care Task Force; Member (2003–present)
  • Children‘s Oncology Group: End-of-Life Care Subcommittee; Committee Member (2002)
  • Roswell Park Cancer Institute: Scientific Review Committee; Co-Chair (2002–2008)
  • Roswell Park Cancer Institute: Medical Staff Executive Committee; Vice President (2002–2007)
  • Roswell Park Cancer Institute: Cancer Committee; Committee Member (2002–present)
  • Children‘s Oncology Group: Data Safety Monitoring Committee; Committee Member (2001)
  • Roswell Park Cancer Institute: Practice Plan Governing Board; Member (2001–2002)
  • Children‘s Oncology Group: Principal Investigator; Member (2001–present)
  • Children‘s Oncology Group: Responsible Investigator, Hematology/Oncology; Member (2001–present)
  • Roswell Park Cancer Institute: Advisory Committee for Clinical Recruitments; Includes SVP for Clinical Programs, Chairs of Med/Surgery; Chair (2000)
  • Women and Children‘s Hospital of Buffalo: Steering Committee; Committee Member (2000)
  • Roswell Park Cancer Institute: Neurology/Neurosurgery Program Task Force; Member (2000)
  • Women and Children‘s Hospital of Buffalo: Pediatric Governance Subcommittee; Committee Member (2000)
  • Women and Children‘s Hospital of Buffalo: Search Committee for Chief of Pediatric Endocrinology; Chair (2000)
  • Pediatric Oncology Group: Institutional Audit (University of Rochester Medical Center, Rochester, NY); Auditor (1999)
  • Health Care Plan; Peer Reviewer (1999)
  • Hemophilia Society: Governance Subcommittee; Committee Member (1999–present)
  • Kaleida Health System: Professional Advisory Committee; Committee Member (1999–present)
  • Kaleida Health System: Visiting Nurses Association; Member (1999–present)
  • Roswell Park Cancer Institute: Continuing Medical Education Committee; Chair (1999–present)
  • Roswell Park Cancer Institute: Friends of Children with Cancer Committee; Committee Member (1999–present)
  • Roswell Park Cancer Institute: Graduate Medical Education Committee (GMEC); Committee Member (1999–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Medical Alumni Association Governing Board; Member (1999–present)
  • Pediatric Oncology Group: Institutional Audit (Hospital for Sick Children, Toronto, Ontario); Auditor (1998)
  • Roswell Park Cancer Institute: Search Committee for Chairman of Radiation Medicine; Committee Member (1998–1999)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 1st Year Medical Students; Student Mentor (1998–1999)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Medical Alumni Association - Medical Student Mentoring Program; Member (1998–1999)
  • Women and Children‘s Hospital of Buffalo: Children‘s Health Task Force of CGF Subcommittee; Committee Member (1998–1999)
  • Women and Children‘s Hospital of Buffalo: Integration of Clinical Services Subcommittee; Committee Member (1998–1999)
  • Women and Children‘s Hospital of Buffalo: CGF Oncology Working Group; Member (1998)
  • Roswell Park Cancer Institute: Annual Protocol Review Committee; Committee Member (1998–present)
  • Roswell Park Cancer Institute: Billing Subcommittee Practice Plan Governing Board; Committee Member (1998–present)
  • Roswell Park Cancer Institute: Clinical Leadership Council; Member (1998–present)
  • Pediatric Oncology Group: Institutional Audit (McGill University, Montreal, Ontario); Auditor (1997)
  • Pediatric Oncology Group: Institutional Audit (Bowman Gray School of Medicine, Winston-Salem, NC); Auditor (1997)
  • Women and Children‘s Hospital of Buffalo: Core Committee for Outcomes Research; Committee Member (1997–1999)
  • Women and Children‘s Hospital of Buffalo: Executive Committee; Committee Member (1997–1999)
  • Women and Children‘s Hospital of Buffalo: CGF Merger Task Force - Credentials Committee; Alternate Member (1997–1998)
  • Women and Children‘s Hospital of Buffalo: Hospital Merger Task Force on Hematology/Oncology; Member (1997–1998)
  • Women and Children‘s Hospital of Buffalo: Community Council; Member (1997)
  • Pediatric Oncology Group: Institutional Audit (Strong Memorial Hospital, Rochester, NY); Auditor (1996)
  • Pediatric Oncology Group: Institutional Audit (East Carolina Medical Center, Greenville, NC); Auditor (1996)
  • Roswell Park Cancer Institute: Blood Products Committee; Committee Member (1996–2004)
  • Roswell Park Cancer Institute: Continuing Medical Education Committee; Co-Chair (1996–1999)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Search Committee for Chairman of Pediatrics; Committee Member (1996–1997)
  • Women and Children‘s Hospital of Buffalo: Development Council Committee; Committee Member (1996–present)
  • Women and Children‘s Hospital of Buffalo: Executive Task Force for Re-Engineering; Member (1995–1998)
  • Association for the Research of Childhood Cancer: Medical/Scientific Advisory Board; Chair (1995–1996)
  • American Society of Pediatric Hematology/Oncology: Health Care Reform and Public Issues Committee; Committee Member (1995–present)
  • Leukemia Society of America, Western New York Chapter: Program Services; Vice President (1995–present)
  • International Journal of Pediatric Hematology/Oncology; Associate Editor (1994–2000)
  • Ronald McDonald House: Program Committee; Chair (1994–2000)
  • Women and Children‘s Hospital of Buffalo: Search Committee for Director of Clinical and Anatomical Pathology; Committee Member (1994–1995)
  • Roswell Park Cancer Institute: Quality Performance Committee; Committee Member (1994–present)
  • Women and Children‘s Hospital of Buffalo: Fellowship Committee; Committee Member (1994–present)
  • Women and Children‘s Hospital of Buffalo: Physician Peer Review Committee; Committee Member (1994–present)
  • National Cancer Institute: CCG Program (Los Angeles, CA); Site Visitor (1993)
  • Ronald McDonald House; Board of Directors (1993–2000)
  • Ronald McDonald House; Executive Board (1993–2000)
  • Camp Good Days and Special Times; Advisory Board (1993–1996)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Residency Program Directors; Member (1993–1996)
  • Roswell Park Cancer Institute: Utilization Review Committee; Committee Member (1993–1994)
  • Roswell Park Cancer Institute: Ethics Committee; Committee Member (1992–2004)
  • Roswell Park Cancer Institute: Scientific Review Committee; Chair (1992–2002)
  • Leukemia Society of America, Western New York Chapter: Professional Education Committee; Committee Member (1992–1994)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Buffalo Physician; Editorial Board Member (1992–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Resident Recruitment Committee; Committee Member (1992–present)
  • National Cancer Institute: POG Program (St. Jude Children‘s Research Hospital, Memphis, TN); Site Visitor (1991)
  • Roswell Park Cancer Institute: Clinical Review Subcommittee - Major Modern.; Committee Member (1990–1995)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Committee on Appointments, Promotions, Tenure and Privileges; Chair (1990–1992)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Student Appeals Committee; Committee Member (1990–1992)
  • Roswell Park Cancer Institute: Medicine/Allied Specialties Representative/Executive Committee; Committee Member (1990–1991)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Curriculum Committee; Committee Member (1990–present)
  • Women and Children‘s Hospital of Buffalo; Advisory Board (1990–present)
  • Women and Children‘s Hospital of Buffalo: Essential Care Program; Member (1990–present)
  • Association for the Research of Childhood Cancer; Board of Directors (1989–present)
  • National Cancer Institute: CCSG Program (University of Michigan, Ann Arbor, MI); Site Visitor (1988)
  • Roswell Park Cancer Institute: Scientific Review Committee; Committee Member (1988–1992)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Committee on Appointments, Promotions, Tenure and Privileges; Committee Member (1988–1990)
  • Western New York Genetics Disease Consortium; Co-Director (1988–1990)
  • Roswell Park Cancer Institute: Quality Assurance Committee; Committee Member (1988–present)
  • National Cancer Institute: CGOP Outreach Program - Special Review Committee (Bethesda, MD); Grant Reviewer (1987)
  • National Cancer Institute: CCOP Outreach Program - Special Review Committee (Bethesda, MD); Grant Reviewer (1987)
  • Roswell Park Cancer Institute: Executive Committee; Committee Member (1987–1993)
  • Roswell Park Cancer Institute: Nutritional Advisory Committee; Committee Member (1987–1989)
  • Association for the Research of Childhood Cancer: Scientific Advisory Board; Member (1987–present)
  • Pediatric Oncology Group: Institutional Audit (Gainesville, FL); Auditor (1986)
  • Women and Children‘s Hospital of Buffalo: Quality Assurance Committee; Committee Member (1986–1993)
  • Leukemia Society of America, Western New York Chapter: Professional Education Committee; Chair (1986–1989)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: 1st Year Medical Students; Teacher (1986–1989)
  • Leukemia Society of America, Western New York Chapter; Board of Trustees Member (1986–present)
  • National Cancer Institute: PDQ; Extramural Board of Associate Editors (1986–present)
  • Women and Children‘s Hospital of Buffalo: Ad Hoc Cancer Committee; Chair (1986–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Curriculum Committee; Chair (1985–1987)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Executive Committee; Committee Member (1985–1987)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council; Secretary (1985–1987)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council Steering Committee; Committee Member (1985–1987)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Pediatric Promotions and Tenure Committee; Committee Member (1985–present)
  • Pediatric Oncology Group: Institutional Audit (Durham, NC); Auditor (1984)
  • Roswell Park Cancer Institute: Pharmacy and Therapeutics Committee; Committee Member (1984–2004)
  • Roswell Park Cancer Institute: Buffalo General Ad Hoc Committee; Committee Member (1984–1985)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: New Course Subcommittee; Chair (1984–1985)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Doctor of Pharmacy Clerkship; Teacher (1984)
  • Roswell Park Cancer Institute: Pharmacy Utilization Committee; Committee Member (1983–1986)
  • Roswell Park Cancer Institute: Infection Control Committee; Committee Member (1982–1991)
  • Roswell Park Cancer Institute: Roswell Park Journal (Clinical Newsletter); Associate Editor (1982–1986)
  • Roswell Park Cancer Institute: Ad Hoc Planning Committee; Committee Member (1982–1984)
  • Women and Children‘s Hospital of Buffalo: Ad Hoc Cancer Committee; Committee Member (1982–present)
  • University at Buffalo Jacobs School of Medicine and Biomedical Sciences: Faculty Council; Member (1980–1990)
  • Cancer Control Program: Pediatric Hematology/Oncology; Roswell Park Cancer Institute, Women and Children‘s Hospital of Buffalo and University at Buffalo; Teacher
  • International Journal of Pediatric Hematology/Oncology; Ad Hoc Reviewer
  • Journal of Bone and Joint Surgery; Ad Hoc Reviewer
  • Journal of Clinical Oncology; Ad Hoc Reviewer
  • Journal of Pediatric Gastroenterology and Nutrition; Ad Hoc Reviewer
  • Pediatric Oncology Group: Hodgkin‘s Disease Core Committee; Committee Member
  • Pediatric Oncology Group: New Agents and Pharmacology Committee; Committee Member
  • Pediatric Oncology Group: Non-Hodgkin‘s Lymphoma Core Committee; Committee Member
  • Selective Cancer Therapeutics Journal; Ad Hoc Reviewer

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Roswell Park Cancer Institute
Department of Pediatrics
Elm and Carlton Streets
Buffalo, NY 14263
Phone: (716) 845-2333
Fax: (716) 845-8003
Email: brecher@buffalo.edu


Log in to Update Your Profile